Acquisition - Additional Information (Details) - USD ($)		12 Months Ended
	Nov. 01, 2021	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022	May 31, 2023
Business Acquisition [Line Items]
Escrow deposit					$ 6,000,000
Amortization of intangible assets		$ 12,300,000	$ 17,300,000	$ 7,600,000
Goodwill		0	351,744,000
Net deferred taxes		0	0
Income tax benefit		73,000	(2,772,000)	(3,480,000)
Lemonaid Health, Inc.
Business Acquisition [Line Items]
Purchase consideration	$ 424,700,000
Consideration transferred, stock awards, vested	8,400,000
Aggregate cash consideration for acquisition	101,900,000
Escrow deposit	$ 13,000,000
Purchase price excludes stock consideration shares issued subject to vest	3,747,027
Acquisition costs	$ 9,400,000
Amortization of intangible assets		$ 11,400,000	$ 16,500,000	7,300,000
Goodwill	351,598,000
Net deferred taxes	6,600,000
Income tax benefit				3,500,000
Foreign deferred tax liability				3,100,000
Revenue recognized				19,200,000
Net loss				$ 22,300,000
Lemonaid Health, Inc. | Consumer and Research Services
Business Acquisition [Line Items]
Goodwill	351,700,000
Goodwill, expected tax deductible amount	$ 0
Lemonaid Health, Inc. | Common Stock Class A
Business Acquisition [Line Items]
Consideration transferred, common stock (in shares)	26,825,241
Purchase consideration stock value	$ 314,400,000
Lemonaid Health, Inc. | Minimum
Business Acquisition [Line Items]
Useful lives	2 years
Lemonaid Health, Inc. | Maximum
Business Acquisition [Line Items]
Useful lives	7 years